AstraZeneca investors press exec-comp chair to tie pay to Pfizer bid
11.06.2014 / Fierce Pharma
Several top AstraZeneca shareholders are pressing for meetings with John Varley, the former CEO of Barclays bank who also happens to head up the drugmaker's remuneration committee, Sky News reports. The aim? To follow through on calls to link AstraZeneca executive pay to the value of Pfizer's rejected buyout offer.